Oral tolerance induction for human food allergy

Area of Science:

• Immunology
• Allergology
• Gastroenterology

Background:

• Food allergies are broadly categorized into IgE-mediated and non-IgE-mediated types.
• Oral tolerance induction (TIFA) is an emerging therapeutic strategy for food allergies.
• Understanding the immunological mechanisms is key to advancing TIFA.

Purpose of the Study:

• To review advances in the immunological basis of food allergy tolerance induction.
• To update on the clinical characteristics of TIFA for different food allergy types.
• To emphasize the role of specific cytokines and cells in successful TIFA.

Main Methods:

• Literature review of studies on food allergy immunotherapy and tolerance induction.
• Analysis of the role of cytokines (IL-10, TGF-β, IFN-γ) and regulatory cells (Treg, Breg).
• Comparison of therapeutic outcomes for IgE-mediated vs. non-IgE-mediated food allergies.

Main Results:

• Interferon-gamma (IFN-γ) is identified as a critical immunomodulatory biologic for TIFA.
• Original SOTI (Specific Oral Tolerance Induction) utilizing IFN-γ shows greater efficacy than conventional methods.
• IFN-γ is particularly essential for the successful tolerance induction in non-IgE-mediated food allergies.

Conclusions:

• Distinguishing between IgE-mediated and non-IgE-mediated food allergies is vital for diagnosis and treatment.
• IFN-γ plays a necessary role in achieving tolerance, especially for non-IgE-mediated food allergies.
• TIFA, particularly with IFN-γ, represents a promising therapeutic avenue for food allergies.